Candel Therapeutics, Inc.
CADL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $279,961 | $260,539 | $178,964 | $308,700 |
| - Cash | $86,963 | $100,687 | $92,165 | $102,654 |
| + Debt | $6,234 | $8,341 | $10,913 | $13,471 |
| Enterprise Value | $199,232 | $168,193 | $97,712 | $219,517 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$195 | -$242 | -$245 | -$245 |
| % Margin | – | – | – | – |
| EBITDA | -$10,913 | -$4,318 | $7,930 | -$13,438 |
| % Margin | – | – | – | – |
| Net Income | -$11,269 | -$4,796 | $7,379 | -$14,073 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.205 | -0.093 | 0.23 | -0.4 |
| % Growth | -120.5% | -140.5% | 157.5% | – |
| Operating Cash Flow | -$10,236 | -$8,891 | -$8,616 | -$5,814 |
| Capital Expenditures | -$144 | -$31 | -$3 | -$3 |
| Free Cash Flow | -$10,380 | -$8,922 | -$8,619 | -$5,817 |